HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes.

Abstract
The proviral integration moloney murine leukaemia virus (Pim) kinases, consisting of Pim-1, Pim-2 and Pim-3, are involved in the control of cell growth, metabolism and differentiation. Pim kinases are emerging as important mediators of adipocyte differentiation. AZD1208 is a pan-Pim kinase inhibitor and is known for its anti-cancer activity. In this study, we investigated the effect of AZD1208 on adipogenesis and lipolysis in 3T3-L1 cells, a murine preadipocyte cell line. AZD1208 markedly suppressed lipid accumulation and reduced triglyceride contents in differentiating 3T3-L1 cells, suggesting the drug's anti-adipogenic effect. On mechanistic levels, AZD1208 reduced not only the expressions of CCAAT/enhancer-binding protein-α (C/EBP-α), peroxisome proliferator-activated receptor-γ (PPAR-γ), fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC) and perilipin A but also the phosphorylation of signal transducer and activator of transcription-3 (STAT-3) in differentiating 3T3-L1 cells. Remarkably, AZD1208 increased cAMP-activated protein kinase (AMPK) and LKB-1 phosphorylation while decreased intracellular ATP contents in differentiating 3T3-L1 cells. Furthermore, in differentiated 3T3-L1 adipocytes, AZD1208 also partially promoted lipolysis and enhanced the phosphorylation of hormone-sensitive lipase (HSL), a key lipolytic enzyme, indicating the drug's HSL-dependent lipolysis. In summary, the findings show that AZD1208 has anti-adipogenic and lipolytic effects on 3T3-L1 adipocytes. These effects are mediated by the expression and/or phosphorylation levels of C/EBP-α, PPAR-γ, FAS, ACC, perilipin A, STAT-3, AMPK and HSL.
AuthorsYu-Kyoung Park, Brice Wilfried Obiang-Obounou, Kyung-Bok Lee, Jong-Soon Choi, Byeong-Churl Jang
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 22 Issue 4 Pg. 2488-2497 (04 2018) ISSN: 1582-4934 [Electronic] England
PMID29441719 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Chemical References
  • AZD1208
  • Biphenyl Compounds
  • CCAAT-Enhancer-Binding Proteins
  • CEBPA protein, mouse
  • Fas protein, mouse
  • PPAR gamma
  • Perilipin-1
  • Pparg protein, mouse
  • Protein Kinase Inhibitors
  • Thiazolidines
  • fas Receptor
  • Proto-Oncogene Proteins c-pim-1
  • proto-oncogene proteins pim
Topics
  • 3T3-L1 Cells
  • Adipocytes (drug effects)
  • Adipogenesis (drug effects)
  • Animals
  • Biphenyl Compounds (pharmacology)
  • CCAAT-Enhancer-Binding Proteins (genetics)
  • Cell Differentiation (drug effects, genetics)
  • Cell Proliferation (drug effects)
  • Gene Expression Regulation, Developmental (drug effects)
  • Lipolysis (drug effects)
  • Mice
  • PPAR gamma (genetics)
  • Perilipin-1 (genetics)
  • Phosphorylation (drug effects)
  • Protein Kinase Inhibitors (pharmacology)
  • Proto-Oncogene Proteins c-pim-1 (antagonists & inhibitors)
  • Thiazolidines (pharmacology)
  • fas Receptor (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: